- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 70
Lilly helps inject $108m into Synthekine
The immuno-oncology therapy developer has amassed at least $190m of overall funding since emerging out of Stanford University.
Jun 11, 2021Lilly helps inject $108m into Synthekine
The immuno-oncology therapy developer has amassed at least $190m of overall funding following a series B round backed by Lilly Asia Ventures.
Jun 11, 2021Daily Deal Round Up: June 10, 2021
Blockchain game developer Mythical Games pulled in $75m while enterprise software developer Morning Consult reached a unicorn valuation in an Advance Venture Partners-led round.
Jun 10, 2021Aiforia visualises $15.4m series B
Helsinki spinout Aiforia has raised an initial $15.4m in series B funding, bringing it halfway to the round’s target.
Jun 10, 2021EcoFlow stores $100m in series B round
The Esid, Great Power and Scud Group-backed portable power storage technology developer received the funding at a $1bn valuation.
Jun 10, 2021Strateos straightens out series B funding
The GV and WuXi AppTec-backed operator of remote laboratory manager has secured $56.1m of new funding from investors including Eli Lilly.
Jun 10, 2021Daily Deal Round Up: June 9, 2021
Financial advice service Credit Sesame pushed its overall funding past $160m while small molecule drug developer Genhouse and AI technology developer Gideon Brothers each raised $31m.
Jun 9, 2021Monogram Health identifies Humana for $160m round
Humana participated in a series B round that boosted the kidney care provider's funding to $172m altogether.
Jun 9, 2021QitanTech keeps pace through $63m series B
The Tsinghua-backed DNA and RNA sequencing equipment manufacturer has added $63m to its coffers.
Jun 9, 2021QitanTech keeps pace through $63m series B
Baidu Ventures has re-upped its commitment to the DNA and RNA sequencing equipment manufacturer, joining investors including Sunshine Insurance’s Riverhead Capital vehicle.
Jun 9, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


